Clinical Trials Logo

Filter by:
NCT ID: NCT04719208 Active, not recruiting - Covid19 Clinical Trials

[COVID-19] Reduction of Sars-CoV-2 Oral Viral Load With Prophylactic Mouth Rinse

Start date: October 6, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of prophylactic mouth rinses in reducing the amount of viruses, specifically SARS-CoV-2 in the oral cavity. This research will guide dental and medical providers on best practices to be performed prior to dental and medical procedures involving the oral cavity.

NCT ID: NCT04718896 Active, not recruiting - Clinical trials for Moderate to Severe Plaque Psoriasis

A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque Psoriasis

BE CONNECTED
Start date: April 6, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess th pharmacokinetics (PK) of bimekizumab administered subcutaneously (sc) in adolescents with moderate to severe plaque psoriasis (PSO).

NCT ID: NCT04718441 Active, not recruiting - Abdominal Injury Clinical Trials

Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)

Start date: May 10, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

This multicenter study aims to evaluate the accuracy of contrast-enhanced ultrasound (CEUS) in diagnosing abdominal solid organ injuries in pediatric patients. Up to 130 subjects will complete the study across approximately 5-10 sites in the US, with up to 30 patients in the training phase (3 per site) and 100 patients in the treatment phase of the study. All subjects will have had a CT scan as part of standard of care, confirming at least one solid organ abdominal injury. The study procedure will occur within 48 hours from time of injury. All subjects will have an abdominal ultrasound without contrast, followed by a contrast-enhanced ultrasound using the contrast agent Lumason. Ultrasound and contrast-enhanced ultrasound results will be compared to the CT scan results. The CT and ultrasound scans will be read locally and will undergo central review.

NCT ID: NCT04718220 Active, not recruiting - Covid19 Clinical Trials

Safety, Testing/Transmission, and Outcomes in Pregnancies With COVID-19

STOPCOVID19
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Pregnant women are a vulnerable and high-risk population, as COVID-19 is associated with an increased risk preterm birth, cesarean section, and maternal critical care. This study will examine the factors that impede testing for SARS-CoV-2 (the causative virus among pregnant women), help determine optimal testing strategies by evaluating the necessity of testing for asymptomatic disease in pregnancy, inform prenatal care plans by assessing the full impact of infection, and contribute to a provider's ability to counsel women and create prenatal care plans if they are pregnant or considering pregnancy.

NCT ID: NCT04718103 Active, not recruiting - Asthma Clinical Trials

A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype

SWIFT-2
Start date: February 4, 2021
Phase: Phase 3
Study type: Interventional

This study will assess the efficacy and safety of GSK3511294 (Depemokimab) as an adjunctive therapy in participants with severe uncontrolled asthma with an eosinophilic phenotype.

NCT ID: NCT04717570 Active, not recruiting - Clinical trials for Mitral Valve Disease

Early Feasibility Study for the Foldax TRIA Mitral Heart Valve Replacement

FOLDAX
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct the initial clinical investigation of the Foldax Polymer Mitral Valve to collect evidence on the device's safety and performance. The study is anticipated to confirm successful clinical safety and clinical effectiveness with significant improvements in clinical hemodynamic performance.

NCT ID: NCT04717336 Active, not recruiting - Clinical trials for Cardiovascular Disease

Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African Americans Study (GENE-FORECAST): Sodium Intervention Trial (SIT)

Start date: January 22, 2021
Phase: Early Phase 1
Study type: Interventional

Background: Hypertension is a risk factor for heart disease. Low-sodium diets rich in fruits, vegetables, and other healthy foods are a good way to reduce blood pressure in people with hypertension. Researchers want to learn more about why African Americans seem to have the greatest benefit from certain dietary interventions. Objective: To better understand the body s response to adding more salt to the diet. Eligibility: U.S.-born African American adults ages 21 to 65 who are in good general health and took part in the GENE-FORECAST. Design: Participants will be screened with a medical history and physical exam. If needed, they will take a pregnancy test. These tests will be repeated during the study. Each day for 2 weeks, participants will take 3 capsules that contain either placebo or salt. Then they will take no pills for 3 weeks. Then they will take placebo or salt capsules for 2 more weeks. Participants will talk about the foods and drinks they have consumed over the past 24 hours. They will take a survey about their physical activity and sleep. Participants will complete taste tasks to obtain their responses to sweetness or saltiness. Sucrose and salt detection thresholds and preferences will be assessed. Participants will give blood and urine samples. Saliva samples will be collected from their mouth by passive drool or by spitting into a sterile tube. Skin samples will be collected from behind their ears and the inner part of their elbow, using sterile swabs. Participants will get kits to collect stool samples at home. Participants will have 4 study visits over 7 weeks.

NCT ID: NCT04716725 Active, not recruiting - Clinical trials for Metastatic Prostate Carcinoma

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

Start date: September 28, 2021
Phase: Phase 2
Study type: Interventional

This phase II trial studies the use of 68Ga-PSMA-11 positron emission tomography (PET) in diagnosing patients with prostate cancer that continues to grow despite the surgical removal of the testes or medical intervention to block androgen production (castration resistant), and has spread to other places in the body (metastatic). 68Ga- PSMA-11 is a new imaging agent that may help get more detailed pictures of the tumor. This trial aims to see whether using 68Ga-PSMA-11 PET scans may help doctors learn more about where disease is located in the body.

NCT ID: NCT04715646 Active, not recruiting - Epilepsy Clinical Trials

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

Start date: March 11, 2021
Phase: Phase 3
Study type: Interventional

The purpose of the study is to evaluate the long-term safety and tolerability of brivaracetam.

NCT ID: NCT04715048 Active, not recruiting - Clinical trials for Glabellar Frown Lines

Split-Face Study Comparing Botox and Jeuveau in Treating Glabellar Lines

Start date: January 1, 2021
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to compare the efficacy and side effects of Botox and Jeuveau for glabellar lines.